DIN 02125323 — HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG 3 MG
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG is a capsule (sustained-release) of Hydromorphone marketed by PURDUE PHARMA. The full Hydromorphone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02125323
- Brand name
- HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG
- Active ingredient
- Hydromorphone
- Strength
- 3 MG
- Dosage form
- CAPSULE (SUSTAINED-RELEASE)
- Route
- ORAL
- Manufacturer
- PURDUE PHARMA
- Health Canada status
- MARKETED
- Drug class
- Opioid analgesic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Hydromorphone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02364115 | APO-HYDROMORPHONE | 1 MG | TABLET | APOTEX INC | MARKETED |
| 02364123 | APO-HYDROMORPHONE | 2 MG | TABLET | APOTEX INC | MARKETED |
| 02364131 | APO-HYDROMORPHONE | 4 MG | TABLET | APOTEX INC | MARKETED |
| 02364158 | APO-HYDROMORPHONE | 8 MG | TABLET | APOTEX INC | MARKETED |
| 02476657 | APO-HYDROMORPHONE CR | 12 MG | CAPSULE (EXTENDED-RELEASE) | APOTEX INC | DORMANT |
| 02476665 | APO-HYDROMORPHONE CR | 18 MG | CAPSULE (EXTENDED-RELEASE) | APOTEX INC | DORMANT |
| 02476673 | APO-HYDROMORPHONE CR | 24 MG | CAPSULE (EXTENDED-RELEASE) | APOTEX INC | DORMANT |
| 02476614 | APO-HYDROMORPHONE CR | 3 MG | CAPSULE (EXTENDED-RELEASE) | APOTEX INC | DORMANT |
| 02476681 | APO-HYDROMORPHONE CR | 30 MG | CAPSULE (EXTENDED-RELEASE) | APOTEX INC | DORMANT |
| 02476622 | APO-HYDROMORPHONE CR | 4.5 MG | CAPSULE (EXTENDED-RELEASE) | APOTEX INC | DORMANT |
| 02476630 | APO-HYDROMORPHONE CR | 6 MG | CAPSULE (EXTENDED-RELEASE) | APOTEX INC | DORMANT |
| 02476649 | APO-HYDROMORPHONE CR | 9 MG | CAPSULE (EXTENDED-RELEASE) | APOTEX INC | DORMANT |
| 00705438 | DILAUDID | 1 MG | TABLET | PURDUE PHARMA | MARKETED |
| 00125083 | DILAUDID | 2 MG | TABLET | PURDUE PHARMA | MARKETED |
| 00125121 | DILAUDID | 4 MG | TABLET | PURDUE PHARMA | MARKETED |
| 00786543 | DILAUDID | 8 MG | TABLET | PURDUE PHARMA | MARKETED |
| 02359502 | HYDROMORPH CONTIN | 4.5 MG | CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02359510 | HYDROMORPH CONTIN | 9 MG | CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02125366 | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG | 12 MG | CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02243562 | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG | 18 MG | CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02125382 | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG | 24 MG | CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02125390 | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG | 30 MG | CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02125331 | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG | 6 MG | CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02145928 | HYDROMORPHONE HP 10 | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02145936 | HYDROMORPHONE HP 20 | 20 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02146126 | HYDROMORPHONE HP 50 | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02460602 | HYDROMORPHONE HYDROCHLORIDE INJECTION | 2 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02460610 | HYDROMORPHONE HYDROCHLORIDE INJECTION HP 10 | 10 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02469413 | HYDROMORPHONE HYDROCHLORIDE INJECTION HP 50 | 50 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02468468 | HYDROMORPHONE HYDROCHLORIDE INJECTION HP FORTE | 100 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02514435 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 1 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02145901 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02529645 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 2 MG | SOLUTION | JAMP PHARMA CORPORATION | DORMANT |
| 02485532 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 20 MG | SOLUTION | STERINOVA INC. | MARKETED |
| 02561603 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 20 MG | SOLUTION | STERINOVA INC. | MARKETED |
| 02485540 | HYDROMORPHONE HYDROCHLORIDE INJECTION USP | 40 MG | SOLUTION | STERINOVA INC. | MARKETED |
| 02491680 | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02491699 | HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 01916386 | PMS HYDROMORPHONE SIROP 1MG/ML | 1 MG | SYRUP | PHARMASCIENCE INC | MARKETED |
| 00885444 | PMS-HYDROMORPHONE TAB 1MG | 1 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 00885436 | PMS-HYDROMORPHONE TAB 2MG | 2 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 00885401 | PMS-HYDROMORPHONE TAB 4MG | 4 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 00885428 | PMS-HYDROMORPHONE TAB 8MG | 8 MG | TABLET | PHARMASCIENCE INC | MARKETED |